GSK plc (GSK:NYSE) closed at $50.75 on October 23, 2026, down 0.90% on the day. The stock trades 17.7% below its 52-week high of $61.70 and 18.4% above its 52-week low of $42.85. Over the past year, it gained 17.4%. GSK plc is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 23, 2025, GSK closed higher on 120 days (48%). Its best day was February 4, 2026 (+7.29%) and its worst was April 29, 2026 (-5.64%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 1 time.
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV, as well as oncology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories under the Otrivin, Panadol, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. GlaxoSmithK...
Find more stocks like GSK with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.